Free PANCE Practice Questions

Neurology PANCE practice questions

10 free, board-style Neurology questions for the PANCE, each with the correct answer and a complete explanation. No email, no account required.

Neurology is 7% of the PANCE content blueprint. These questions come from the clinician-reviewed FirstPassPA bank. Attempt each one before you reveal the answer.

Question 1NeurologyMedium
A 28-year-old woman presents with a 6-month history of bilateral, band-like, pressing (non-pulsatile) headaches occurring 2-3 times per week and lasting 4-6 hours. The pain is mild to moderate, is not worsened by routine activity, and is not associated with nausea, vomiting, photophobia, or phonophobia. Neurologic exam is normal. She has not previously tried any therapy. Which of the following is the most appropriate first-line treatment for her acute headaches?
  • AOral tizanidine
  • BOral ibuprofen
  • COral butalbital
  • DOral sumatriptan
  • EOral verapamil
Reveal answer & full explanation
Correct answer: B — Oral ibuprofen
  • AOral tizanidine
  • BOral ibuprofen✓
  • COral butalbital
  • DOral sumatriptan
  • EOral verapamil

Why oral ibuprofen is correct

  • Episodic tension-type headache is the most common primary headache disorder: bilateral, pressing or tightening (non-pulsatile) pain of mild to moderate intensity, not aggravated by routine physical activity, and without nausea or significant photophobia/phonophobia
  • First-line acute therapy is a simple analgesic — NSAIDs (ibuprofen, naproxen) or acetaminophen — with NSAIDs generally preferred for efficacy, per current AAFP and international headache society guidance
  • Patients should be counseled to limit use to fewer than 10–15 days/month to avoid medication-overuse headache

Why the others are wrong

  • Oral sumatriptan — 5-HT1B/1D agonist for acute migraine; triptans are not effective for tension-type headache. Trap: buzzword-matching recurrent headache to migraine despite the stem excluding every migraine feature (pulsatile quality, nausea, photophobia/phonophobia, activity aggravation)
  • Oral verapamil — calcium channel blocker used for cluster headache prophylaxis; it is neither an acute therapy nor a tension-type headache drug. Trap: right-drug-wrong-disease plus prophylaxis-versus-acute confusion
  • Oral butalbital — butalbital-containing combination analgesics are specifically discouraged for tension-type headache because of sedation, dependence, and a high rate of medication-overuse headache; they are never the opening move in a patient who has tried no therapy. Trap: escalating to a sedative combination pill before a simple analgesic has been tried
  • Oral tizanidine — centrally acting alpha-2 agonist muscle relaxant that appeals to the idea that tension-type headache is a disorder of tight muscles; muscle relaxants are not supported by good evidence for acute tension-type headache and add sedation and hypotension. Trap: treating the name of the headache instead of choosing the simple analgesic the evidence supports

Additional high-yield points

  • For frequent or chronic tension-type headache, amitriptyline is first-line prophylaxis
Question 2NeurologyMedium
A 55-year-old man with small cell lung cancer develops ptosis and proximal muscle weakness that improves with repetitive use. An edrophonium (Tensilon) test is negative, and serum anti-voltage-gated calcium channel (anti-VGCC) antibodies are positive. Which of the following is the most likely diagnosis?
  • ACushing syndrome from ectopic ACTH
  • BGeneralized myasthenia gravis
  • CAmyotrophic lateral sclerosis
  • DParaneoplastic dermatomyositis
  • ELambert-Eaton myasthenic syndrome
Reveal answer & full explanation
Correct answer: E — Lambert-Eaton myasthenic syndrome
  • ACushing syndrome from ectopic ACTH
  • BGeneralized myasthenia gravis
  • CAmyotrophic lateral sclerosis
  • DParaneoplastic dermatomyositis
  • ELambert-Eaton myasthenic syndrome✓

Why Lambert-Eaton myasthenic syndrome is correct

  • Lambert-Eaton myasthenic syndrome (LEMS) is a paraneoplastic disorder most often associated with small cell lung cancer, caused by autoantibodies against presynaptic voltage-gated calcium channels.
  • Reduced acetylcholine release produces proximal weakness and hyporeflexia that characteristically IMPROVE with brief repetitive activity (post-exercise facilitation) — the opposite of myasthenia gravis.
  • Positive anti-VGCC antibodies and a negative edrophonium response point to a presynaptic disorder rather than a postsynaptic acetylcholine-receptor disease.
  • Management is treatment of the underlying malignancy plus amifampridine (3,4-diaminopyridine).

Why the others are wrong

  • Amyotrophic lateral sclerosis — causes mixed upper and lower motor neuron signs without an autoantibody or post-exercise facilitation (buzzword-matching weakness to a motor neuron disease).
  • Generalized myasthenia gravis — a postsynaptic acetylcholine-receptor disease in which weakness WORSENS with sustained or repetitive activity and the edrophonium test is typically positive; its tumor association is thymoma, not small cell lung cancer, so neither the facilitation pattern nor the antibody here fits; chosen by anchoring on ptosis.
  • Paraneoplastic dermatomyositis — proximal weakness accompanied by a heliotrope rash, Gottron papules, and elevated creatine kinase, not antibody-mediated neuromuscular-junction failure with facilitation (premature closure on paraneoplastic proximal weakness).
  • Cushing syndrome from ectopic ACTH — small cell lung cancer is the classic source of ectopic ACTH, and the resulting hypercortisolism causes a proximal myopathy, but steroid myopathy spares the eyelids, does not improve with repeated effort, and is not antibody-mediated; it typically comes with hypokalemia, hypertension, and hyperglycemia rather than ptosis and anti-VGCC antibodies (buzzword-matching small cell lung cancer to its endocrine syndrome).
Question 3NeurologyMedium
A 68-year-old man develops an asymmetric resting tremor, bradykinesia, and cogwheel rigidity over the past year. He is started on levodopa/carbidopa with marked symptomatic improvement. Loss of dopaminergic neurons in which of the following structures best explains his symptoms?
  • ASubstantia nigra pars compacta
  • BNucleus basalis of Meynert
  • CSubthalamic nucleus
  • DVentral tegmental area
  • ELocus coeruleus
Reveal answer & full explanation
Correct answer: A — Substantia nigra pars compacta
  • ASubstantia nigra pars compacta✓
  • BNucleus basalis of Meynert
  • CSubthalamic nucleus
  • DVentral tegmental area
  • ELocus coeruleus

Why Substantia nigra pars compacta is correct

  • Parkinson disease results from degeneration of dopaminergic neurons in the substantia nigra pars compacta, reducing dopamine output to the striatum via the nigrostriatal pathway and producing the cardinal motor features.
  • The marked response to levodopa/carbidopa confirms a dopamine-deficient nigrostriatal circuit.

Why the others are wrong

  • Nucleus basalis of Meynert — cholinergic nucleus that degenerates in Alzheimer disease, producing memory loss rather than parkinsonism (confused-with another neurodegenerative pathway).
  • Locus coeruleus — the principal noradrenergic nucleus; its loss is implicated in mood and arousal changes, not the dopaminergic motor deficit (buzzword-matching a brainstem nucleus).
  • Ventral tegmental area — gives rise to the mesolimbic and mesocortical dopamine pathways involved in reward and cognition, not the nigrostriatal motor pathway (anchoring on 'dopamine' without localizing).
  • Subthalamic nucleus — the glutamatergic subthalamic nucleus is a familiar Parkinson disease structure because it becomes overactive when nigral dopamine is lost and is a standard deep brain stimulation target, but it contains no dopaminergic neurons and is not the site of neuronal loss; a focal lesion produces contralateral hemiballismus (confused-with the deep brain stimulation target).
Question 4NeurologyMedium
A 45-year-old man reports recurrent episodes of severe, lancinating pain across his right cheek and upper lip lasting only seconds, triggered by chewing, talking, or light touch to that area. Neurologic examination is normal. Which of the following is the most appropriate first-line pharmacotherapy?
  • ACarbamazepine
  • BIndomethacin
  • CAmitriptyline
  • DGabapentin
  • EVerapamil
Reveal answer & full explanation
Correct answer: A — Carbamazepine
  • ACarbamazepine✓
  • BIndomethacin
  • CAmitriptyline
  • DGabapentin
  • EVerapamil

Why Carbamazepine is correct

  • Trigeminal neuralgia presents with brief paroxysms of unilateral lancinating facial pain in a trigeminal branch distribution (V2/V3 most common), triggered by innocuous stimuli such as chewing, talking, or light touch, with a normal neurologic exam between attacks.
  • Carbamazepine is first-line pharmacotherapy per AAN/EFNS and EAN guidance; it dampens the ectopic sodium-channel firing that drives the paroxysms. Oxcarbazepine is an accepted alternative.
  • Microvascular decompression is reserved for medication-refractory cases.

Why the others are wrong

  • Verapamil — first-line prophylaxis for cluster headache, whose attacks last 15-180 minutes with ipsilateral autonomic features rather than seconds-long touch-triggered jolts (buzzword-matching severe unilateral facial pain to the wrong syndrome).
  • Indomethacin — the defining treatment for paroxysmal hemicrania, but those attacks last minutes, occur with ipsilateral autonomic signs, and are not triggered by light touch (confused-with-paroxysmal-hemicrania trap for brief unilateral facial pain).
  • Amitriptyline — first-line for persistent (atypical) idiopathic facial pain, which is constant, dull, and poorly localized, unlike the seconds-long triggered paroxysms here (confused-with-atypical-facial-pain trap).
  • Gabapentin — a reflexive choice for neuropathic pain such as postherpetic neuralgia, but in classic trigeminal neuralgia it is a second-line or add-on agent with weaker evidence than carbamazepine, so it is not the first-line drug for these touch-triggered paroxysms (confused-with-generic-neuropathic-pain trap).
Question 5NeurologyMedium
A 46-year-old woman comes to the emergency department after a headache began abruptly at 7:15 AM and reached maximum intensity within seconds; she vomited twice on the way in. She has never had a headache like this and takes no medications. On arrival at 8:00 AM the temperature is 36.9 C, blood pressure is 152/94 mm Hg, and pulse is 88/min. She is awake and fully oriented, the neck is supple, and the neurologic examination, including funduscopy, is normal. A noncontrast head CT completed at 9:20 AM on the department multidetector scanner is read by the neuroradiologist on duty as showing no subarachnoid, intraparenchymal, or intraventricular blood. Which of the following is the most appropriate next step in management?
  • AIntravenous labetalol for blood pressure control
  • BAdmission for nimodipine and close observation
  • CDischarge with return precautions and follow-up
  • DLumbar puncture for cerebrospinal fluid studies
  • ERepeat the noncontrast head CT in 6 to 12 hours
Reveal answer & full explanation
Correct answer: C — Discharge with return precautions and follow-up
  • AIntravenous labetalol for blood pressure control
  • BAdmission for nimodipine and close observation
  • CDischarge with return precautions and follow-up✓
  • DLumbar puncture for cerebrospinal fluid studies
  • ERepeat the noncontrast head CT in 6 to 12 hours

Why Discharge with return precautions and follow-up is correct

  • A headache that reaches maximum intensity within seconds is aneurysmal subarachnoid hemorrhage (SAH) until proven otherwise, and the first test is a noncontrast head CT.
  • Work out the interval before deciding what the scan means: onset was 7:15 AM and the CT was completed at 9:20 AM, so it was obtained about 2 hours after onset, inside the 6-hour window, on a multidetector scanner read by a neuroradiologist, in a woman who is awake, fully oriented, and neurologically normal. That is the population in which the rule was derived and validated.
  • In exactly that setting a normal noncontrast CT rules out nontraumatic SAH: ACEP 2019 gives this a Level B recommendation, and the pooled data behind it show sensitivity 98.7%, a negative likelihood ratio of 0.010, and missed SAH in 1.46 per 1,000 scans; the 2023 AHA/ASA aneurysmal SAH guideline agrees (Class 2a) for the patient who presents within 6 hours of onset, as she did.
  • Nothing in the stem points toward the other dangerous causes, and an unenhanced CT does not formally exclude them, which is why the disposition carries explicit precautions rather than bare reassurance: she is afebrile with a supple neck, funduscopy and the neurologic examination are normal, and this is a single first-ever attack in a woman taking no medications. The blood pressure of 152/94 mm Hg is the expected pain response to a severe headache rather than a hypertensive emergency, which takes far higher pressures with acute end-organ damage, so it does not redirect the workup. The next step is therefore symptomatic treatment, a scheduled follow-up visit, and explicit return precautions for a second thunderclap headache, fever, neck stiffness, or any new neurologic symptom.

Why the others are wrong

  • Lumbar puncture for cerebrospinal fluid studies - CT followed by LP is the pathway for the patient who presents outside the 6-hour window or with a new neurologic deficit, where the 2023 AHA/ASA guideline gives it a Class 1 recommendation; a qualifying early scan has already answered the SAH question here, and a headache that peaks within seconds is not the tempo of meningitis, which builds over hours to days. Tapping her now carries a real rate of traumatic taps and post-LP headache for a vanishingly small yield, and xanthochromia is not reliably present until roughly 12 hours after onset, so a negative xanthochromia this early would add nothing the qualifying CT has not already settled (the trap is running the CT-then-LP reflex on a CT that has already answered the question).
  • Repeat the noncontrast head CT in 6 to 12 hours - subarachnoid blood grows less dense and less conspicuous as it is cleared, so a second unenhanced scan is less sensitive than the first; a later CT rescues nothing, adds radiation, and only delays disposition (the trap is treating an early scan as premature when it is in fact the most sensitive one).
  • Admission for nimodipine and close observation - nimodipine reduces delayed cerebral ischemia and improves neurologic outcome after a confirmed aneurysmal SAH, where the 2023 AHA/ASA guideline makes it a Class 1 recommendation, and it is used off label in reversible cerebral vasoconstriction syndrome (RCVS), but neither diagnosis is established: the qualifying early CT excludes SAH, and RCVS is defined by reversible segmental narrowing of the cerebral arteries, which takes vascular imaging she has not had and which most often declares itself through repeated thunderclap attacks over days to weeks rather than one episode (the trap is treating a diagnosis that has not been established).
  • Intravenous labetalol for blood pressure control - the 152/94 mm Hg reading invites treatment because blood pressure is lowered in aneurysmal SAH until the aneurysm is secured, but the qualifying early CT has excluded hemorrhage, and a modest rise without acute end-organ damage is the expected pain response rather than a hypertensive emergency, so intravenous antihypertensive therapy has no indication here (the trap is treating a number instead of the diagnosis).

Additional high-yield points

  • The 6-hour rule is conditional, and each document sets its own conditions: ACEP 2019 (Level B) asks for a normal noncontrast head CT obtained within 6 hours of symptom onset on a minimum third-generation scanner in a patient with a normal neurologic examination, while the 2023 AHA/ASA guideline (Class 2a) sets its window by presentation within 6 hours of onset and asks for a high-quality scan interpreted by a board-certified neuroradiologist. If the scan falls outside the window, the equipment or the reader does not meet that standard, or the patient has a focal deficit, papilledema, or depressed consciousness, do not stop at the CT.
  • Anchor the window to symptom onset rather than to arrival or to the time the study was ordered; a patient who waited at home can be outside the window on a scan that feels early in the visit.
  • When concern for SAH survives a nondiagnostic noncontrast CT, which is usually the beyond-6-hour situation, the workup continues rather than stopping: the 2023 AHA/ASA guideline gives noncontrast CT followed by LP a Class 1 recommendation beyond 6 hours or with a new neurologic deficit, and ACEP (Level C) lets lumbar puncture or CT angiography of the head be chosen by shared decision making in any patient still considered to be at risk after a negative scan.
  • A normal early CT excludes SAH but not every dangerous cause of thunderclap headache. Cerebral venous sinus thrombosis is the classic miss, since the unenhanced scan is usually normal and the study that finds it is CT or MR venography; cervical artery dissection is suggested by neck pain or a Horner syndrome, RCVS by repeated attacks or exposure to a vasoactive drug, pituitary apoplexy by visual field loss with hypopituitarism, and meningitis by fever and meningismus. That residual list, together with the cerebrospinal fluid diagnoses a lumbar puncture would have caught, is why return precautions and a scheduled visit rather than bare reassurance end this encounter.
  • ACEP 2019 also gives a Level A recommendation to preferentially use nonopioid rather than opioid medications in the treatment of acute primary headache in the emergency department, a recommendation that applies once a secondary cause like this one has been excluded.
  • The Ottawa SAH Rule (age 40 years or older, neck pain or stiffness, witnessed loss of consciousness, onset during exertion, thunderclap onset, limited neck flexion on examination) is highly sensitive but poorly specific, so it decides who gets imaged rather than who has bled.
Question 6NeurologyMedium
A 58-year-old man presents with progressive difficulty walking and sharp, lightning-like pains in his legs over the past year. He reports urinary incontinence and a history of an untreated genital ulcer 20 years ago. On exam, he has a wide-based gait, absent patellar and Achilles reflexes, loss of vibratory and position sense in the lower extremities, and small irregular pupils that constrict to accommodation but not to light. Romberg sign is positive. Which of the following is the most likely diagnosis?
  • AMultiple sclerosis
  • BDiabetic sensory polyneuropathy
  • CTabes dorsalis
  • DNormal pressure hydrocephalus
  • ESubacute combined degeneration
Reveal answer & full explanation
Correct answer: C — Tabes dorsalis
  • AMultiple sclerosis
  • BDiabetic sensory polyneuropathy
  • CTabes dorsalis✓
  • DNormal pressure hydrocephalus
  • ESubacute combined degeneration

Why tabes dorsalis is correct

  • Tabes dorsalis is a late manifestation of tertiary neurosyphilis, with Treponema pallidum damaging the dorsal columns and dorsal roots, typically 15-25 years after an untreated primary infection (the remote genital ulcer).
  • Dorsal column degeneration produces loss of vibratory and position sense, sensory ataxia with a wide-based gait and a positive Romberg, and absent lower-extremity reflexes; lancinating "lightning" pains are characteristic.
  • Argyll Robertson pupils — small, irregular pupils that accommodate but do not react to light — are essentially pathognomonic.
  • Confirm with serum treponemal testing and treat neurosyphilis with IV penicillin G.

Why the others are wrong

  • Diabetic sensory polyneuropathy — a length-dependent neuropathy that can blunt vibratory and position sense, abolish ankle reflexes, and cause lancinating pain, but nothing in this history suggests diabetes and it does not account for the small irregular pupils with light-near dissociation or the remote untreated chancre (confused-with another cause of sensory ataxia).
  • Subacute combined degeneration — vitamin B12 deficiency damages the dorsal columns AND lateral corticospinal tracts, producing hyperreflexia and upgoing toes, not the areflexia here, and never Argyll Robertson pupils (confused-with another dorsal-column disease).
  • Multiple sclerosis — affects younger patients with relapsing-remitting CNS lesions and causes optic neuritis or internuclear ophthalmoplegia, not Argyll Robertson pupils or this syphilis history (premature closure on the common demyelinating diagnosis).
  • Normal pressure hydrocephalus — a wide-based gait with urinary incontinence in an older man recalls the normal pressure hydrocephalus triad, but its magnetic gait comes with cognitive decline rather than loss of vibratory and position sense, the reflexes are preserved rather than absent, and it accounts for neither the lightning pains nor the light-near dissociation of the pupils (confused-with the gait-and-incontinence triad)
Question 7NeurologyMedium
A 45-year-old man has severe, strictly unilateral orbital pain lasting 30-90 minutes, accompanied by ipsilateral lacrimation, rhinorrhea, and ptosis. The attacks have occurred one or more times daily in bouts for the past 6 weeks. Which of the following is the most appropriate acute treatment?
  • AOral verapamil therapy
  • BIntramuscular ketorolac
  • COral propranolol
  • DHigh-flow 100% oxygen
  • ENSAID with oral caffeine
Reveal answer & full explanation
Correct answer: D — High-flow 100% oxygen
  • AOral verapamil therapy
  • BIntramuscular ketorolac
  • COral propranolol
  • DHigh-flow 100% oxygen✓
  • ENSAID with oral caffeine

Why high-flow 100% oxygen is correct

  • The picture — strictly unilateral periorbital pain lasting 15 minutes to 3 hours with ipsilateral cranial autonomic features (lacrimation, rhinorrhea, ptosis) occurring in daily bouts — is a cluster headache.
  • High-flow 100% oxygen by non-rebreather mask aborts 70-80% of attacks within 15 minutes and is a first-line acute treatment.
  • Subcutaneous sumatriptan is the other first-line abortive; both act fast enough for the short, severe attacks.

Why the others are wrong

  • Oral propranolol — a migraine preventive, not a cluster abortive, and far too slow for an attack that peaks in minutes (right-category-wrong-headache).
  • NSAID with oral caffeine — useful for migraine or tension-type headache but not effective for cluster attacks (buzzword-matching on "headache").
  • Intramuscular ketorolac — a parenteral NSAID is a reasonable rescue for migraine but has no established efficacy in cluster headache, and its onset is far slower than oxygen or subcutaneous sumatriptan for pain that peaks within minutes (buzzword-matching on "injectable analgesic").
  • Oral verapamil therapy — verapamil is the first-line preventive during a cluster period, which ties it to the right headache, but it takes days to weeks of titration to suppress attacks and cannot abort an attack that peaks within minutes (right-headache-wrong-phase).

Additional high-yield points

  • Verapamil is first-line for prevention during a cluster period.
Question 8NeurologyMedium
A 70-year-old man reports a 5-year history of bilateral hand tremor that is present when he holds a cup or writes and is absent when his hands rest in his lap. The tremor improves after he drinks a glass of wine. Examination shows a symmetric tremor of both hands with the arms outstretched and during finger-to-nose testing, which he performs accurately. Tone, rapid alternating movements, gait, and the remainder of the neurologic examination are normal. Which of the following is the most likely diagnosis?
  • AEssential tremor
  • BDystonic tremor
  • CPhysiologic tremor
  • DParkinson disease
  • ECerebellar tremor
Reveal answer & full explanation
Correct answer: A — Essential tremor
  • AEssential tremor✓
  • BDystonic tremor
  • CPhysiologic tremor
  • DParkinson disease
  • ECerebellar tremor

Why Essential tremor is correct

  • Essential tremor is a bilateral action/postural tremor that appears with sustained posture and movement (holding a cup, writing) and is absent at rest.
  • Improvement after alcohol is a classic, highly suggestive feature of essential tremor.
  • Normal tone and rapid alternating movements exclude the rigidity and bradykinesia of a parkinsonian syndrome, and accurate finger-to-nose testing with a normal gait excludes the dysmetria and ataxia of a cerebellar process.
  • It is the most common movement disorder; first-line therapy is propranolol or primidone.

Why the others are wrong

  • Cerebellar tremor — an intention tremor that worsens on approaching a target and is accompanied by dysmetria and gait ataxia, neither of which is present; it does not improve with alcohol (buzzword-matching a movement-related tremor to an intention tremor)
  • Physiologic tremor — a fine, low-amplitude postural tremor that is normally invisible; the enhanced physiologic tremor becomes visible with a reversible trigger such as anxiety, caffeine, thyrotoxicosis, or a beta-agonist, and neither explains a 5-year bilateral tremor that improves with alcohol (premature closure on a "normal" finding)
  • Parkinson disease — produces a resting tremor with bradykinesia and rigidity, all absent here (anchoring on tremor in an older adult)
  • Dystonic tremor — a postural and action tremor of the hands that is often mistaken for essential tremor, but it arises in a body part affected by dystonia, is typically asymmetric and jerky, and may ease at a null point, whereas this man has a symmetric tremor on an otherwise normal examination without dystonic posturing (confused-with the other action tremor)
Question 9NeurologyMedium
A 22-year-old woman develops symmetric weakness that begins in her feet and ascends over several days, 3 weeks after an episode of Campylobacter gastroenteritis. On examination she has flaccid weakness with absent deep tendon reflexes and is developing difficulty breathing. Sensation is preserved. Cerebrospinal fluid analysis shows protein 180 mg/dL with a white blood cell count of 4/mm³. Which of the following is the most likely diagnosis?
  • ATick paralysis
  • BMyasthenia gravis
  • CFoodborne botulism
  • DMultiple sclerosis
  • EGuillain-Barré syndrome
Reveal answer & full explanation
Correct answer: E — Guillain-Barré syndrome
  • ATick paralysis
  • BMyasthenia gravis
  • CFoodborne botulism
  • DMultiple sclerosis
  • EGuillain-Barré syndrome✓

Why Guillain-Barré syndrome is correct

  • Guillain-Barré syndrome presents with ascending symmetric flaccid weakness and areflexia, often 1-3 weeks after Campylobacter jejuni gastroenteritis; AIDP is the common demyelinating form, while post-Campylobacter cases are classically the pure motor axonal variant (AMAN)
  • Cerebrospinal fluid shows albuminocytologic dissociation — elevated protein (180 mg/dL) with a normal cell count (4/mm³)
  • Preserved sensation and early respiratory difficulty fit an evolving acute motor polyneuropathy, so serial vital capacity must be followed
  • Treatment is IVIG or plasmapheresis; corticosteroids are not effective

Why the others are wrong

  • Myasthenia gravis — causes fatigable weakness with normal reflexes and normal CSF, and is not triggered by an antecedent gastrointestinal infection (premature closure on weakness)
  • Tick paralysis — an attached tick's neurotoxin also produces ascending flaccid areflexic weakness with preserved sensation, but the CSF is normal rather than showing the albuminocytologic dissociation reported here, and it follows tick attachment rather than Campylobacter (confused-with-another-ascending-paralysis)
  • Multiple sclerosis — a relapsing central demyelinating disease, not an acute ascending flaccid paralysis with areflexia after Campylobacter (buzzword-matching on "demyelination")
  • Foodborne botulism — a recent gastrointestinal illness, flaccid weakness with preserved sensation, and respiratory compromise can point to an ingested toxin, but botulinum toxin causes a descending paralysis that begins with cranial nerve signs such as ptosis, diplopia, and dysphagia, often with poorly reactive pupils, and the CSF is normal rather than showing the albuminocytologic dissociation reported here (confused-with-a-descending-paralysis)
Question 10NeurologyMedium
A 72-year-old man comes to the emergency department 8 hours after the sudden onset of a mild right facial droop and mild weakness of the right arm and leg. He has hypertension and hyperlipidemia, takes no antiplatelet or anticoagulant medication, and has no history of gastrointestinal or intracranial bleeding. Pulse is 76/min and fingerstick glucose is 104 mg/dL. He is fully alert with fluent speech; he holds the right arm and the right leg against gravity with mild drift in each, and the National Institutes of Health Stroke Scale score is 3. ECG and continuous telemetry since arrival show normal sinus rhythm. Noncontrast CT of the head shows no hemorrhage, and diffusion-weighted MRI shows a small acute infarct in the left corona radiata. Which of the following is the most appropriate antithrombotic strategy?
  • AAspirin plus clopidogrel for 21 days, then aspirin alone
  • BAspirin alone, started now and continued indefinitely
  • CApixaban alone, started now and continued indefinitely
  • DIntravenous heparin for 5 days, then aspirin alone
  • EAspirin plus clopidogrel for 12 months, then aspirin alone
Reveal answer & full explanation
Correct answer: A — Aspirin plus clopidogrel for 21 days, then aspirin alone
  • AAspirin plus clopidogrel for 21 days, then aspirin alone✓
  • BAspirin alone, started now and continued indefinitely
  • CApixaban alone, started now and continued indefinitely
  • DIntravenous heparin for 5 days, then aspirin alone
  • EAspirin plus clopidogrel for 12 months, then aspirin alone

Why Aspirin plus clopidogrel for 21 days, then aspirin alone is correct

  • Sudden focal deficits with a small acute infarct on diffusion-weighted imaging and no hemorrhage on CT make this an acute ischemic stroke, and an NIHSS score of 3 with sinus rhythm makes it a minor noncardioembolic stroke
  • For minor ischemic stroke with an NIHSS score of 3 or less, or high-risk TIA with an ABCD2 score of 4 or more, aspirin plus clopidogrel is started early, ideally within 12 to 24 hours of symptom onset; at 8 hours he is well inside that window
  • CHANCE and POINT each cut 90-day recurrent stroke by roughly a quarter to a third compared with aspirin alone, and the benefit is concentrated in the first 2 to 3 weeks, when recurrence risk peaks
  • Guidelines accept 21 to 90 days of the pair, and 21 days is the usual choice because the 21-day course in CHANCE added no excess major bleeding, whereas in the 90-day course in POINT the ischemic benefit was confined to the early weeks while major bleeding kept accruing
  • He is antithrombotic-naive with no gastrointestinal or intracranial bleeding history, so he has no feature that would make a second antiplatelet agent unsafe
  • The second agent is then dropped and a single antiplatelet agent is continued indefinitely; typical dosing is an aspirin load of 160 to 325 mg with a clopidogrel load of 300 to 600 mg, then aspirin 81 mg plus clopidogrel 75 mg daily

Why the others are wrong

  • Aspirin alone, started now and continued indefinitely - aspirin monotherapy is exactly the comparator arm that CHANCE and POINT beat, and it is the right therapy only after the second agent comes off; with no bleeding history to weigh against it, starting one agent today forfeits the first 3 weeks, when recurrence risk is highest and two agents carry a Class 1 recommendation (the trap is the reflex to give aspirin and stop there)
  • Aspirin plus clopidogrel for 12 months, then aspirin alone - the right two drugs for a duration no stroke guideline supports: past the first weeks the reduction in recurrent stroke flattens while major bleeding keeps accumulating, so the second agent comes off between day 21 and day 90; 12 months of dual therapy belongs to coronary stenting (the trap is importing the post-stent DAPT duration into stroke)
  • Apixaban alone, started now and continued indefinitely - oral anticoagulation is the answer when the mechanism is cardioembolic, and his ECG and continuous telemetry show sinus rhythm with a small deep infarct; anticoagulation does not lower early recurrence in noncardioembolic stroke and it raises symptomatic intracranial hemorrhage (the trap is treating an acute arterial thrombus the way a cardioembolic clot is treated)
  • Intravenous heparin for 5 days, then aspirin alone - early heparin was once the reflex for a fresh infarct, which is why it tempts while he is still inside the first day; trials of early heparin and heparinoids found that any fall in early recurrence was offset by more intracranial and extracranial bleeding with no better outcome, so guidelines advise against urgent anticoagulation to prevent early recurrence or halt worsening, and the first weeks belong to dual antiplatelet therapy (the trap is reaching for an anticoagulant to stop an evolving stroke)

Additional high-yield points

  • The deficit, not the clock, is what keeps him from a thrombolytic: he is 8 hours out, past the standard 4.5-hour window, and the 2026 AHA/ASA guideline allows IV thrombolysis from 4.5 to 9 hours only when automated perfusion imaging shows salvageable penumbra, but at any time point a mild nondisabling deficit is rated no benefit for IV thrombolysis and short-course dual antiplatelet therapy is given instead; thrombectomy is the reperfusion option the clock still allows out to 24 hours but it applies to a large-vessel occlusion rather than a small deep infarct like his, and when a thrombolytic is given a single tenecteplase 0.25 mg/kg bolus up to 25 mg is an accepted alternative to an alteplase infusion, with only one thrombolytic ever given
  • MATCH and SPS3 are the trials behind the bleeding ceiling on dual therapy, and SPS3 enrolled only recent lacunar infarcts; both began the pair weeks to months after the index event and continued it for 18 months to about 3 years, so they bound how long two agents are given rather than whether the short course is started, and a small deep infarct with an NIHSS score of 3 or less still gets the 21-day course
  • Short-course dual antiplatelet therapy applies to patients who did not receive thrombolysis; after IV thrombolysis antiplatelet agents are withheld for 24 hours and a follow-up head CT is obtained first
  • Ticagrelor plus aspirin for 30 days (THALES) is an alternative short course, and CYP2C19 loss-of-function carriers derive less benefit from clopidogrel (CHANCE-2), but ticagrelor carries a weaker recommendation and is not a co-equal first choice
  • Prolonged rhythm monitoring to hunt occult atrial fibrillation belongs to cryptogenic and embolic strokes rather than to a clear small-vessel lacune like this one; wherever atrial fibrillation is found the regimen becomes an oral anticoagulant, with the start timed to infarct size, within a few days for a small infarct and later for a large one, and never as an urgent heparin infusion
  • Carotid endarterectomy within 2 weeks is added to antiplatelet therapy for a cortical stroke ipsilateral to 70 to 99 percent internal carotid stenosis; a small deep infarct like this one is small-vessel disease, not a carotid lesion
  • The rest of secondary prevention is high-intensity statin therapy, blood pressure below 130/80 mm Hg, and glycemic and smoking-cessation management

That's 10 of 7,700+. Get the rest.

Unlock the full FirstPassPA bank: 7,700+ board-style questions across every organ system, flashcards, and an AI tutor that explains every answer. Your 7-day free trial includes everything, and there's no credit card required.

Start your 7-day free trial → See today's free PANCE question →

Neurology PANCE practice: FAQ

Are these Neurology PANCE practice questions free?

Yes. Each question shows the full vignette, the correct answer, and a complete explanation, with no email or account required. A free 7-day trial unlocks the full 7,700+ question bank, flashcards, and an AI tutor.

How much of the PANCE is Neurology?

Neurology makes up 7% of the PANCE content blueprint. FirstPassPA's timed PANCE exams are dealt to the same weights, so a practice exam carries the same share of Neurology questions.

How should I use these questions?

Attempt each vignette before you reveal the answer, then read the full explanation even when you got it right: the reasons each wrong choice is wrong are where most of the learning is. When you are ready for more, practice Neurology questions in the app, or take a full timed PANCE practice exam dealt to the blueprint weights.

Educational use only. These questions are a study aid for PA students and are not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.